共 62 条
[1]
Sung H(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-49
[2]
Ferlay J(2010)Hodgkin lymphoma across the age spectrum: epidemiology, therapy, and late effects Semin Radiat Oncol 20 30-44
[3]
Siegel RL(2019)Epidemiology, outcome, targeted agents and immunotherapy in adolescent and young adult non-Hodgkin and Hodgkin lymphoma Br J Haematol 185 1142-1157
[4]
Punnett A(2019)Efficacy of nivolumab as checkpoint inhibitor drug on survival rate of patients with relapsed/refractory classical Hodgkin lymphoma: a meta-analysis of prospective clinical study Clin Transl Oncol 21 1093-1103
[5]
Tsang RW(2000)Epstein–Barr virus-associated malignancies: epidemiologic patterns and etiologic implications Crit Rev Oncol Hematol 34 27-53
[6]
Hodgson DC(2006)Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS J Blood 108 3786-3791
[7]
Metzger ML(2006)Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia J Natl Cancer Inst 98 1321-1330
[8]
Mauz-Körholz C(2021)Long-term residential exposure to air pollution and Hodgkin lymphoma risk among adults in Denmark: a population-based case–control study Cancer Causes Control 32 935-942
[9]
Amraee A(2018)Hodgkin lymphoma Textbook Cancer Epidemiol 49 725-736
[10]
Evazi MR(2010)NORDCAN—a Nordic tool for cancer information, planning, quality control and research Acta Oncol 19 335-351